Daniel J. Abrams
Fondateur chez Cerebral Therapeutics, Inc.
Postes actifs de Daniel J. Abrams
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cerebral Therapeutics, Inc.
Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | - | - | |
President | 01/01/2010 | 24/09/2019 |
Historique de carrière de Daniel J. Abrams
Anciens postes connus de Daniel J. Abrams
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sierra Neuropharmaceuticals, Inc.
Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Directeur/Membre du Conseil | 26/06/2009 | 14/04/2010 |
Directeur Technique/Scientifique/R&D | 25/06/2009 | 19/05/2011 | |
Fondateur | 14/04/2010 | 19/05/2011 | |
President | 14/04/2010 | 23/02/2011 | |
University of Colorado Health Sciences Center | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 2 |
Founder | 2 |
President | 2 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Sierra Neuropharmaceuticals, Inc.
Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Health Technology |
Cerebral Therapeutics, Inc.
Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Commercial Services |
- Bourse
- Insiders
- Daniel J. Abrams
- Expérience